ArticleBiomedicines2022

Robustness of the Krebs Cycle under Physiological Conditions and in Cancer: New Clues for Evaluating Metabolism-Modifying Drug Therapies.

Rafael Franco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.